Delivery Order SPE2DB20D3303-SPE2DB24FA3DT

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,550,884 units of Fluticasone Prop HFA 220 MCG 12GM, a prescription medication. The contract has a firm fixed price of $2,484.87 and an ultimate completion date of August 23, 2024. This contract is not a set-aside. AmerisourceBergen Drug Corp has been awarded multiple contracts by the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, worth $8,948.68, is for the supply of 4,565,285,694 units of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The award has an ultimate completion date of July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, to provide 4,564,855,740 units of the drug fluticasone propionate HFA 110 mcg 12 gm. The contract has a ceiling value of $8,729.78 and is a firm-fixed price delivery order, with an ultimate completion date of June 11, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,192.77, is for the supply of 4562534156 Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to support federal medical requirements. The contract has an ultimate completion date of October 20, 2023 and was awarded on October 19, 2023. No set-aside designation was used. AmerisourceBergen holds a...
This is a $3,964.79 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a prescription medication. The contract has an ultimate completion date of July 9, 2025 and is a firm fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,739 units of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The contract, valued at $2,096.01, has an ultimate completion date of April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,084.04, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. It is a firm fixed-price contract with a period of performance through March 31, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,667.32, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 31, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,611.42, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a completion date of October 20, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a $3,547.48 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of 4,564,375,420 units of Fluticasone Prop HFA 110 MCG 12GM, a prescription pharmaceutical product. The contract has an ultimate completion date of April 24, 2024 and does not include a set-aside designation. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA3DT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 4,565,833,587 units of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a firm fixed price of $7,210.67 and a completion date of September 18, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of essential medical commodities, including specialty medications, generic drugs, and medical supplies, to support military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide.

Generated 12/17/24, 9:08 AM